title: Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis.
authors.forename: Marc E
authors.initials: ME
authors.lastname: Rothenberg
authors.forename: Seema
authors.initials: S
authors.lastname: Aceves
authors.forename: Peter A
authors.initials: PA
authors.lastname: Bonis
authors.forename: Margaret H
authors.initials: MH
authors.lastname: Collins
authors.forename: Nirmala
authors.initials: N
authors.lastname: Gonsalves
authors.forename: Sandeep K
authors.initials: SK
authors.lastname: Gupta
authors.forename: Ikuo
authors.initials: I
authors.lastname: Hirano
authors.forename: Chris A
authors.initials: CA
authors.lastname: Liacouras
authors.forename: Phil E
authors.initials: PE
authors.lastname: Putnam
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Spergel
authors.forename: Alex
authors.initials: A
authors.lastname: Straumann
authors.forename: Barry K
authors.initials: BK
authors.lastname: Wershil
authors.forename: Glenn T
authors.initials: GT
authors.lastname: Furuta
mesh_terms: D055808:Drug Discovery; D057765:Eosinophilic Esophagitis / Q000188:drug therapy*; D006801:Humans; D035583:Rare Diseases / Q000188:drug therapy*